SkinBioTherapeutics plc (AIM: SBTX)
Health Care · Biotechnology · GB
£0.05
-11.00% today · -59.7% 1Y
SkinBioTherapeutics plc (AIM: SBTX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $20.57M.
Over the last twelve months the share price has lost 59.7%, trading between 0.05 and 0.23.
Tweenvest scores SkinBioTherapeutics plc across four factors: quality 38/100, value 58/100. Its strongest factor is value.
SBTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $20.57M
- Revenue (TTM)
- $7.04M
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.26
- 52-week high
- £0.23
- 52-week low
- £0.05
- Avg volume (3M)
- —
- Shares outstanding
- 259.17M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Radiopharm Theranostics LimitedASX: RAD | $21.10M | AU$0.01 | -12.50% |
| APTOCROM Inc.KOSDAQ: A109960 | $20.97M | ₩1,867.00 | +0.70% |
| Defence Therapeutics Inc.CNSX: DTC | $20.73M | CA$0.39 | -17.02% |
| MaaT Pharma SAENXTPA: MAAT | $20.73M | €0.93 | -5.39% |
| Taiwan Advance Bio-Pharmaceutical Inc.TPEX: 4186 | $20.48M | NT$7.25 | -0.68% |
| ProBiotix Health PlcOFEX: PBX | $20.40M | £0.10 | -2.50% |
| Estrella Immunopharma, Inc.NasdaqCM: ESLA | $20.36M | $0.42 | -10.28% |
| EOM Pharmaceuticals Holdings, Inc.OTCPK: IMUC | $20.10M | $0.16 | -1.97% |
Figures last refreshed Oct 4, 2026.